BridgeMD
New treatment option for Gingival Cleft
Official title Gingival Cleft Development at Two Time Points of Canine Retraction
ClinicalTrials.gov ID: NCT07210762
What this study is testing
- What it's testing
- The goal of this split-mouth randomized controlled trial is to assess whether the timing of extraction space closure-early vs. delayed initiation-affects the incidence of gingival cleft development in orthodontic patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults. Healthy volunteers may be eligible.
You may be able to join if
- Extraction advised of both first premolars from either maxilla, mandible or both.
- All permanent dentition present apart from third molars.
You likely can't join if
- Severe crowding
- Smokers
- Patients with systemic diseases that could interfere with bone remodeling.
- Patients with periodontitis or poor periodontal health.
- Patients who have previously undergone periodontal surgery in the area of interest.
- Patients with other oral health conditions that could complicate the treatment or healing process.
The study team makes the final eligibility decision.
Where it's taking place
- Karachi, Sindh, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Karachi, Sindh, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.